Avascular necrosis of the jaws: Risk factors in metastatic cancer patients

被引：116

作者：

Tarassoff, P ^{[1
]}

Csermak, K

机构：

[1] Novartis Pharmaceut, E Hanover, NJ USA

[2] Novartis Pharma AG, Basel, Switzerland

来源：

关键词：

D O I：

10.1016/j.joms.2003.09.001

中图分类号：

R78 [口腔科学];

学科分类号：

1003 ;

摘要：

[No abstract available]

引用

页码：1238 / 1239

页数：2

共 6 条

[1] Alendronate in the treatment of avascular necrosis of the hip [J].

Agarwala, S ;

Sule, A ;

Pai, BU ;

Joshi, VR .

Åstrand, J ;

Aspenberg, P .

[3]

Fleisch H., 2000, BISPHOSPHONATES BONE, P34

Mirzai, R ;

Chang, C ;

Greenspan, A ;

Gershwin, ME .

SCHWARTZ, HC .

HEAD & NECK SURGERY, 1982, 4 (03) :251-253

[6]

Sung Eric C, 2002, Spec Care Dentist, V22, P142, DOI 10.1111/j.1754-4505.2002.tb01178.x